Soleus Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
1,092,110
+275,500
| +34% | +$2.58M | 0.68% | 37 |
|
|
2025
Q1 | $10M | Sell |
816,610
-1,675,390
| -67% | -$20.6M | 0.72% | 36 |
|
|
2024
Q4 | $32.9M | Buy |
2,492,000
+1,401,016
| +128% | +$18.5M | 2.07% | 14 |
|
|
2024
Q3 | $21M | Buy |
1,090,984
+264,484
| +32% | +$5.09M | 1.63% | 19 |
|
|
2024
Q2 | $17M | Buy |
826,500
+457,500
| +124% | +$9.39M | 1.5% | 26 |
|
|
2024
Q1 | $8.78M | Sell |
369,000
-145,000
| -28% | -$3.45M | 0.65% | 46 |
|
|
2023
Q4 | $11.1M | Buy |
514,000
+394,500
| +330% | +$8.53M | 1.23% | 26 |
|
|
2023
Q3 | $1.74M | Sell |
119,500
-93,100
| -44% | -$1.35M | 0.16% | 70 |
|
|
2023
Q2 | $4.45M | Sell |
212,600
-110,000
| -34% | -$2.3M | 0.49% | 51 |
|
|
2023
Q1 | $6.81M | Buy |
322,600
+102,600
| +47% | +$2.17M | 0.71% | 40 |
|
|
2022
Q4 | $5.6M | Buy |
+220,000
| New | +$5.6M | 0.8% | 36 |
|
|
2020
Q2 | – | Sell |
-20,980
| Closed | -$230K | – | 67 |
|
|
2020
Q1 | $230K | Hold |
20,980
| – | – | 0.27% | 42 |
|
|
2019
Q4 | $184K | Buy |
+20,980
| New | +$184K | 0.18% | 49 |
|